Skip to content

Charles Casamento

Director at GT Biopharma.

Earliest Form D on file: Mar 2025

GT Biopharma

Biotech, San Francisco CA

Director

  • Signed
  • Named
  • Size is amount sold

Filings

3
  • May 28, 2025

    Equity, named · Form D

    $0

    of $20M

  • May 27, 2025

    Equity, option to acquire, security to be acquired, named · Form D

    $5.95M

    of $5.95M

  • Mar 7, 2025

    Equity, option to acquire, security to be acquired, named · Form D

    $1.3M

    of $1.3M

Network

At GT Biopharma

6 people